Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan
Lina Madaniyazi, Xerxes Seposo, Chris Fook Sheng Ng, Aurelio Tobias, Michiko Toizumi, Hiroyuki Moriuchi, Lay-Myint Yoshida, Masahiro Hashizume
Abstract
Nonpharmaceutical interventions (NPIs) for COVID-19 can affect the current and future dynamics of respiratory syncytial virus infections (RSV). In Tokyo, RSV activity declined by 97.9% (95% CI: 94.8%-99.2%) during NPIs. A long period of NPIs could increase susceptible populations, thus enhancing the potential for large RSV outbreaks after the end of NPIs.
Topics & Concepts
OutbreakRespiratory systemPandemicVirologyVirusMedicineCoronavirus disease 2019 (COVID-19)PneumovirinaeSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Psychological intervention2019-20 coronavirus outbreakBiologyAffect (linguistics)MononegaviralesVirus diseasesRespiratory infectionEpidemiologyEnvironmental healthRespiratory viral infections researchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing